Abstract:Background- Tetrahydrobiopterin (BH4) is an essential cofactor of endothelial nitric oxide synthase (eNOS). When BH4 levels are decreased, eNOS becomes uncoupled to produce superoxide anion (O-2(-)) instead of NO, which contributes to endothelial dysfunction. Deoxycorticosterone acetate (DOCA) - salt hypertension is characterized by a suppressed plasma renin level due to sodium retention but manifests in eNOS uncoupling; however, how endogenous BH4 regulates blood pressure is unknown. GTP cyclohydrolase I (GTPCH I) is the rate-limiting enzyme for de novo BH4 synthesis. This study tested the hypothesis that endothelium-specific GTPCH I overexpression retards the progression of hypertension through preservation of the structure and function of resistance mesenteric arteries.Methods and Results- During 3 weeks of DOCA-salt treatment, arterial blood pressure was increased significantly in wild-type mice, as determined by radiotelemetry, but this increase was attenuated in transgenic mice with endothelium-specific GTPCH I overexpression (Tg-GCH). Arterial GTPCH I activity and BH4 levels were decreased significantly in wild-type DOCA-salt mice, but both were preserved in Tg-GCH mice despite DOCA-salt treatment. Significant remodeling of resistance mesenteric arteries (approximate to 100-mu m outside diameter) in wild-type DOCA-salt mice exists, evidenced by increased medial cross-sectional area, media thickness, and media-lumen ratio and overexpression of tenascin C, an extracellular matrix glycoprotein that contributes to hypertrophic remodeling; all of these effects were prevented in DOCA-salt - treated Tg-GCH mice. Furthermore, NO-mediated relaxation in mesenteric arteries was significantly improved in DOCA-salt - treated Tg-GCH mice, in parallel with reduced O-2(-) levels. Finally, phosphorylation of eNOS at serine residue 1177 (eNOS-(S1177)), but not its dimer-monomer ratio, was decreased significantly in wild-type DOCA-salt mice compared with sham controls but was preserved in DOCA-salt - treated Tg-GCH mice.Conclusions- These results demonstrate that endothelium-specific GTPCH I overexpression abrogates O-2(-) production and preserves eNOS phosphorylation, which results in preserved structural and functional integrity of resistance mesenteric arteries and lowered blood pressure in low-renin hypertension.

Deficiency of Volume-Regulated ClC-3 Chloride Channel Attenuates Cerebrovascular Remodelling in DOCA-salt Hypertension.

Volume-Regulated Chloride Channels And Cerebral Vascular Remodelling

Integrin Β3 Mediates Cerebrovascular Remodelling Through Src/ClC-3 Volume-Regulated Cl(-) Channel Signalling Pathway.

Alteration of Volume-Regulated Chloride Movement in Rat Cerebrovascular Smooth Muscle Cells During Hypertension.

Integrin Beta 3 Mediates Cerebrovascular Remodelling Through Src/Clc-3 Volume-Regulated Cl- Channel Signalling Pathway

Low Chloride–Regulated ClC-5 Contributes to Arterial Smooth Muscle Cell Proliferation and Cerebrovascular Remodeling

Abstract WP255: Cftr Deficiency Increases Systolic Blood Pressure and Exacerbates Cerebrovascular Remodeling in Angiotensin-induced Hypertension

Enigmatic Chloride Channels Ő How to Contribute to Cerebrovascular Remodeling (841.10)

Downregulation of TMEM16A Calcium-Activated Chloride Channel Contributes to Cerebrovascular Remodeling During Hypertension by Promoting Basilar Smooth Muscle Cell Proliferation.

Abstract 8: Deletion Of The Alpha Subunit Of EnNaC And MTORC2 Inhibition Attenuate DOCA-salt-induced Endothelial Cell And Vascular Stiffness.

Signifance of expression of MMP-2/TIMP-2 and the effect of the intervention of amlodipine in DHR heart

Regulation Of Intracellular Cl- Concentration Through Volume-Regulated Clc-3 Chloride Channels In A10 Vascular Smooth Muscle Cells

LRRC8A is essential for volume‐regulated anion channel in smooth muscle cells contributing to cerebrovascular remodeling during hypertension

TRPC3 Channel Confers Cerebrovascular Remodelling During Hypertension Via Transactivation of EGF Receptor Signalling

Section 2: Cardiovascular Pharmacology

Vascular smooth muscle-specific LRRC8A knockout ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting the WNK1/FOXO3a/MMP signaling pathway

ClC-2 knockdown prevents cerebrovascular remodeling via inhibition of the Wnt/β-catenin signaling pathway

Endothelium-Specific Gtp Cyclohydrolase I Overexpression Attenuates Blood Pressure Progression In Salt-Sensitive Low-Renin Hypertension

Abstract 305: Pressure Overload-Induced Myocardial Hypertrophy Causes an Electrical Remodeling of CLC-3 Chloride Channels in Mouse Heart

Chloride Channels - New Targets for the Prevention of Stroke.

Beta3 Adrenergic Receptor is Involved in Vascular Injury in Deoxycorticosterone Acetate‐salt Hypertensive Mice